Driving Antifungals Market Growth in 2025: The Role of Rising Prevalence Of Fungal Infections Boosts Antifungals Market

Driving Antifungals Market Growth in 2025: The Role of Rising Prevalence Of Fungal Infections Boosts Antifungals MarketUse code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antifungals Market Size Growth Forecast: What to Expect by 2025?
In the past few years, there has been robust growth in the size of the antifungals market, expanding from $27.01 billion in 2024 to an estimated $29.67 billion in 2025. This signifies a compound annual growth rate (CAGR) of 9.8%. This appreciable growth encountered in the historical period can be credited to factors like the rise in the incidence of fungal diseases, an increasing older population, enhancements in healthcare infrastructure, and improvements in awareness and education.

How Will the Antifungals Market Size Evolve and Grow by 2029?
In the coming years, we anticipate that the antifungals market will experience significant growth, projecting a rise to $41.84 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this expected growth in the forecast period include emerging fungal strains, regulatory approvals, international health concerns, increased spending in healthcare, as well as patient education and awareness. Key trends for the forecast period involve research and development, telemedicine and e-health, advancements in the development of antifungal drugs, and collaborations and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

What Drivers Are Propelling the Growth of Antifungals Market Forward?
The rise in fungal infections is anticipated to trigger an expansion in the antifungals market. Fungal diseases occur as a result of fungal invasions and development in or on the body. They can impact various body parts, such as skin, nails, lungs, and mucous membranes. The heightened occurrence of such infections is linked to a growing population of individuals with compromised immune systems, climate variations fostering the ideal conditions for fungal proliferation, overuse of broad-spectrum antibiotics that disturb natural microbiomes, inadequate hygiene, urban development, and the increasing occurrences of chronic diseases like diabetes that make individuals more susceptible to fungal infections. Antifungals are essential in combating fungal diseases, restrict fungal growth and reproduction, either by interfering with the cell wall or membrane, blocking crucial enzymatic processes, or impeding their ability to generate crucial components, thereby lessening the fungal load, relieving symptoms, and preventing infection spread within the body. For instance, the International Society For Infectious Diseases, a US-based non-profit organization, reported in September 2024, an annual incidence of 6.5 million invasive fungal infections linked to about 3.8 million deaths, with 2.5 million (68%; range 35-90%) directly resulting from these infections. Therefore, the rising occurrence of fungal infections is predicted to stimulate the antifungals market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp

Which Emerging Trends Are Transforming the Antifungals Market in 2025?
Companies involved in the development and production of drugs are increasing their expansion in departments like research and development, marketing, and production through cooperation and strategic alliances with other firms and research institutes. Thus, entities in the anti-infective drugs market could consider these collaborations strategically to expand their horizon and product offerings, resulting in increased revenue and maintaining competitiveness in the market.

What Are the Key Segments in the Antifungals Market?
The antifungals market covered in this report is segmented -

1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines
2) By Route of Administration: Oral, Parenteral, Topical
3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users

Subsegments
1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin
2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, conazole
3) By Polyenes: Amphotericin B, Nystatin
4) By Allylamines: Terbinafine, Naftifine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp

Who Are the Key Players Shaping the Antifungals Market's Competitive Landscape?
Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

What Geographic Markets Are Powering Growth in the Antifungals Market?
North America was the largest region in the drugs for antifungals market in 2023. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2442

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.